Screening Cancer Readiness Through Education and Empowerment for Newcomer Women
SCREEN
The Effect of Online Education on Knowledge and Attitudes Toward Cancer Screening Among Migrant Women: A Randomized Controlled Trial
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
Purpose: This study was conducted to determine the effect of an online educational intervention on migrant women's knowledge and attitudes toward cancer screening. DesigN:This study was designed as a two-arm, parallel-group, randomized controlled trial with pre-test and post-test assessments. Method: The study population will consist of women registered at the Cancer Early Diagnosis, Screening and Training Center (KETEM) affiliated with the Erzincan Provincial Health Directorate. The sample size was calculated based on a two-group (intervention and control) and two-measurement (pre-test and post-test) study design. Using repeated-measures ANOVA with a medium effect size (d = 0.25), a significance level of 5% (α = 0.05), and a statistical power of 80% (1 - β = 0.80), the required sample size was determined to be 34 participants per group (34 in the intervention group and 34 in the control group), resulting in a minimum total sample of 68 participants. To account for potential attrition, it was planned to recruit 80 participants (approximately 20% more than the minimum required sample size).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2026
CompletedStudy Start
First participant enrolled
August 6, 2026
CompletedFirst Posted
Study publicly available on registry
August 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 25, 2027
August 10, 2026
August 1, 2026
5 months
August 5, 2026
August 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cancer Screening Knowledge Scale
The Cancer Screening Knowledge Scale is a 25-item questionnaire designed to assess participants' knowledge regarding cancer screening. Total scores range from 0 to 25, with higher scores indicating greater knowledge.
From baseline to 5 weeks after baseline
Cancer Screening Attitude Scale-Short Form
The Cancer Screening Attitude Scale-Short Form is a 15-item questionnaire used to assess participants' attitudes toward cancer screening. Total scores range from 15 to 75, with higher scores indicating more positive attitudes toward cancer screening.
From baseline to 5 weeks after baseline
Study Arms (2)
SCREEN
EXPERIMENTALcontrol group
ACTIVE COMPARATORInterventions
Women assigned to the intervention group will be contacted by telephone using the contact information registered at the Cancer Early Diagnosis, Screening and Training Center (KETEM). For participants without a registered telephone number, home visits will be conducted using the addresses recorded in the KETEM database. Following completion of the baseline (pre-test) assessment, participants in the intervention group will receive an online cancer screening education program developed in accordance with the Turkish National Cancer Control Program of the General Directorate of Public Health, Ministry of Health of the Republic of Türkiye. The educational intervention will be delivered in three online sessions via WhatsApp video calls. During each session, participants will have the opportunity to ask questions, which will be answered by the researcher. Prior to each session, reminder text messages will be sent to participants' mobile phones to notify them of the date and time of the schede
Women assigned to the control group who are registered at the Cancer Early Diagnosis, Screening and Training Center (KETEM) will be contacted and invited to participate in the study. During the initial meeting, written informed consent will be obtained, after which the Personal Information Form and study questionnaires will be administered to collect baseline (pre-test) data. An appointment for the follow-up assessment will be scheduled approximately four weeks later. Five weeks after the baseline assessment, participants will be contacted by telephone to complete the post-test assessment. No educational intervention will be provided to the control group during the study period. After completion of the post-test assessment, participants in the control group will be offered the same cancer screening education program in accordance with the ethical principle of equity.
Eligibility Criteria
You may qualify if:
- Women aged 30-70 years. Able to read and write. Able to speak and understand Turkish. Have access to the internet at home or in the workplace. Own a smartphone or have access to a smartphone belonging to a family member that can be used by the participant.
- Have no hearing, visual, cognitive, or orthopedic impairments that would prevent participation in the study.
You may not qualify if:
- Diagnosis of a psychiatric disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 5, 2026
First Posted
August 10, 2026
Study Start
August 6, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
January 25, 2027
Last Updated
August 10, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share